LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU=Giroux Leprieur Etienne
  2. AU="Xinhui Gao"
  3. AU="Christoph Schlapbach"
  4. AU="Akbar, Shayista"
  5. AU="Butler, Eboneé N"
  6. AU="Moura-Alves, Márcio"
  7. AU="Marcet, Ismael"
  8. AU=Eichfelder Sebastian
  9. AU=Timins M E
  10. AU="Weber, Stephan"
  11. AU=Galuska David
  12. AU="Carrieri, Mariella"
  13. AU="Hafkamp, Frederique J"
  14. AU="Jessica M. Perkins"
  15. AU="Tariq, Syeda Sumayya"
  16. AU="Meehan, Rebecca"

Search results

Result 1 - 10 of total 79

Search options

  1. Article ; Online: Incidental diagnosis of lung cancer on chest CT scan performed for suspected or documented COVID-19 infection.

    Wang, Pascal / Martel, Patricia / Hajjam, Mostafa El / Grimaldi, Lamiae / Giroux Leprieur, Etienne

    Respiratory medicine and research

    2024  Volume 85, Page(s) 101084

    Abstract: Context: Recent studies have shown a benefit of chest computed tomography (CT scan) in lung cancer screening. The COVID-19 pandemic has led to many chest CT scan performed on a large population. The objective of this study was to describe the incidence ... ...

    Abstract Context: Recent studies have shown a benefit of chest computed tomography (CT scan) in lung cancer screening. The COVID-19 pandemic has led to many chest CT scan performed on a large population. The objective of this study was to describe the incidence and characteristics of lung cancer detected on chest CT scan, outside the framework of a clinical trial, for a suspected or documented COVID-19 infection.
    Methods: We conducted a multicenter study, carried out from the analysis of data from the prospective COVID-19 database of the Clinical Data Warehouse of the Greater Paris University Hospitals (AP-HP). We identified the patients who had been diagnosed with a lung cancer, due to a chest CT scan done for a suspected or confirmed COVID-19 infection. The study period was limited to the first two epidemic lockdowns: (03/01/20 - 05/31/20) and (10/10/20 - 11/30/20).
    Results: Over the study period, 24 390 patients had at least one chest CT scan. Among them, 72 lung cancer diagnoses were made (incidence 0.30 %; median age 67.4 years old, 50.0 % current smokers, 55.6 % adenocarcinoma). Half of the lung cancer patients (n = 36) did not meet the National Lung Screening Trial inclusion criteria. Twenty-six patients (36.1 %) were diagnosed at an early stage, 25 (34.7 %) of whom received radical curative treatment. Twenty-six patients died during the follow-up (36.1 %) but none in early stages. The median overall survival in lung cancer patients was 693 days [532 - NA].
    Conclusions: A large-scale chest CT scan strategy for suspected or documented COVID-19 infection has allowed a significant proportion of early-stage lung cancer diagnosis, all of which have benefited from curative treatment.
    Language English
    Publishing date 2024-01-12
    Publishing country France
    Document type Journal Article
    ISSN 2590-0412
    ISSN (online) 2590-0412
    DOI 10.1016/j.resmer.2024.101084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer.

    Belaidi, Lahcene / Wang, Pascal / Quintin, Kevin / Durdux, Catherine / Giroux-Leprieur, Etienne / Giraud, Philippe

    Cancers

    2023  Volume 15, Issue 21

    Abstract: Stereotactic radiotherapy (SRT) is gaining increasing importance in metastatic non-small-cell lung cancer (mNSCLC) management. The optimal sequence of tumor irradiation relative to systemic treatment remains unclear. If waiting response evaluation to ... ...

    Abstract Stereotactic radiotherapy (SRT) is gaining increasing importance in metastatic non-small-cell lung cancer (mNSCLC) management. The optimal sequence of tumor irradiation relative to systemic treatment remains unclear. If waiting response evaluation to first-line systemic therapy (FLST) before considering local treatment may allow for the exclusion of poorer prognosis progressive tumors that may not benefit from SRT, performing irradiation near immune check point inhibitor (ICI) first administration seems to improve their synergic effect. Herein, we aimed to determine whether delaying SRT after response evaluation to FLST would result in better prognosis. We compared overall survival (OS), progression-free survival (PFS), and time to first subsequent therapy (TFST) for 50 patients locally treated before or within 90 days of initiating FLST (early SRT), with 49 patients treated at least 90 days after initiating FLST (late SRT). Patients treated with conventional chemotherapy alone exhibited significantly poorer median OS, PFS, and TFST in the early SRT arm: (in months) 16.5 [8.33-NR] vs. 58.3 [35.05-NR] (
    Language English
    Publishing date 2023-10-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15215127
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report.

    Magdelaine, Pierre / Costantini, Adrien / Fabre, Lucie / Giroux-Leprieur, Etienne

    Thoracic cancer

    2022  Volume 13, Issue 13, Page(s) 1994–1997

    Abstract: Herein, we report a case of a 73-year-old female patient diagnosed with cT4N0M1a lung adenocarcinoma with KRAS G12C mutation, PDL1 < 1% and treated in fourth-line setting with gemcitabine after progression under nivolumab. After one infusion of ... ...

    Abstract Herein, we report a case of a 73-year-old female patient diagnosed with cT4N0M1a lung adenocarcinoma with KRAS G12C mutation, PDL1 < 1% and treated in fourth-line setting with gemcitabine after progression under nivolumab. After one infusion of gemcitabine, the patient presented with an acute worsening of general condition (performance status 4) with extensive skin lesions and fever, leading to hospitalization and diagnosis of acute generalized exanthematous pustulosis. Initial blood work revealed multiple organ failures with an important inflammatory syndrome. Patient state improved after intravenous hydration and local and systemic corticosteroids. The decision was made to stop systemic cancer treatment. Two months follow-up showed a remarkable response on all cancer localizations. Although immunotherapy is transforming cancer care, predicting response to immunotherapy remains challenging and resistant mechanisms remain mostly unknown. This case underlines that important immune-stimulation can lead to tumor response in a patient previously refractory to all antitumor treatments.
    MeSH term(s) Acute Generalized Exanthematous Pustulosis/diagnosis ; Acute Generalized Exanthematous Pustulosis/etiology ; Adenocarcinoma of Lung/complications ; Adenocarcinoma of Lung/drug therapy ; Aged ; Deoxycytidine/analogs & derivatives ; Female ; Humans ; Neoplasms/complications ; Nivolumab/adverse effects
    Chemical Substances Deoxycytidine (0W860991D6) ; Nivolumab (31YO63LBSN) ; gemcitabine (B76N6SBZ8R)
    Language English
    Publishing date 2022-05-26
    Publishing country Singapore
    Document type Case Reports
    ZDB-ID 2625856-0
    ISSN 1759-7714 ; 1759-7706
    ISSN (online) 1759-7714
    ISSN 1759-7706
    DOI 10.1111/1759-7714.14405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy.

    Malapelle, Umberto / Leprieur, Etienne Giroux / Kamga, Paul Takam / Chiasseu, Marius Tresor / Rolfo, Christian

    Frontiers in oncology

    2021  Volume 11, Page(s) 694578

    Language English
    Publishing date 2021-05-14
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2021.694578
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case-Control Study.

    Ezzedine, Rémy / Canellas, Anthony / Naltet, Charles / Wislez, Marie / Azarian, Reza / Seferian, Andrei / Giroux Leprieur, Etienne

    Cancers

    2023  Volume 15, Issue 18

    Abstract: The current first-line standard treatment for advanced small cell lung cancer (SCLC) is a combination of chemotherapy and immunotherapy. However, few efficacy data are available in a real-life settings, including frail patients. The aim of this study is ... ...

    Abstract The current first-line standard treatment for advanced small cell lung cancer (SCLC) is a combination of chemotherapy and immunotherapy. However, few efficacy data are available in a real-life settings, including frail patients. The aim of this study is to describe the real-life efficacy of chemoimmunotherapy in an unselected SCLC population. We conducted a retrospective multicenter study, which compared two cohorts of patients with treatment-naive metastatic SCLC treated in six academic centers in the Greater Paris area. Cohort 1 included patients treated with chemotherapy between January 2017 and December 2018, and cohort 2 included patients treated with chemoimmunotherapy between January 2019 and December 2020. A total of 153 consecutive patients were included (cohort 1: n = 96; cohort 2: n = 57). Clinical characteristics were similar between the two cohorts. Overall survival (OS) was statistically higher in cohort 2 (median survival 15.47 months) than in cohort 1 (median survival 9.5 months) (p = 0.0001). OS for patients with a performance status ≥2 and for patients ≥70 years old was not statistically different between the two cohorts. Chemoimmunotherapy efficacy was better compared to chemotherapy alone in case of brain or liver metastases. In conclusion, the combination of chemoimmunotherapy in metastatic SCLC appears to provide a real-life OS benefit. Dedicated clinical trials are needed to test this strategy in patients with impaired performance status or advanced age.
    Language English
    Publishing date 2023-09-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15184593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Crizotinib : enfin l'AMM en 1(re) ligne des cancers bronchiques non à petites cellules de stade avancé ALK.

    Giroux Leprieur, Etienne / Wislez, Marie

    Bulletin du cancer

    2016  Volume 103, Issue 2, Page(s) 125–126

    Title translation Crizotinib: At last in first-line treatment of advanced-stage ALK-rearranged non-small cell lung cancer.
    MeSH term(s) Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/genetics ; Clinical Trials as Topic ; Disease-Free Survival ; Drug Resistance, Neoplasm/genetics ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/enzymology ; Lung Neoplasms/genetics ; Mutation ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Pyrazoles/adverse effects ; Pyrazoles/therapeutic use ; Pyridines/adverse effects ; Pyridines/therapeutic use ; Receptor Protein-Tyrosine Kinases/genetics
    Chemical Substances Protein Kinase Inhibitors ; Pyrazoles ; Pyridines ; crizotinib (53AH36668S) ; Receptor Protein-Tyrosine Kinases (EC 2.7.10.1) ; anaplastic lymphoma kinase (EC 2.7.10.1)
    Language French
    Publishing date 2016-02
    Publishing country France
    Document type Letter
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2015.12.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Spécificités de la prise en charge du cancer bronchique du sujet âgé.

    Leprieur, Etienne Giroux

    Soins. Gerontologie

    2012  , Issue 96, Page(s) 26–30

    Abstract: The diagnosis and treatment of elderly patients with lung cancer must take into account a number of specificities. The geriatric assessment is a fundamental stage in the initial examination.The treatment of localised forms involves surgery, with a ... ...

    Title translation Lung cancer in the elderly: diagnostic and treatment specifics.
    Abstract The diagnosis and treatment of elderly patients with lung cancer must take into account a number of specificities. The geriatric assessment is a fundamental stage in the initial examination.The treatment of localised forms involves surgery, with a slightly higher morbimortality in elderly compared to younger patients, resulting in the need for a rigorous selection of patients. Advanced forms are treated with chemotherapy or targeted therapies, treatment which is adapted to the patient and the tumour.
    MeSH term(s) Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Decision Making ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/therapy ; Pneumonectomy ; Radiotherapy
    Chemical Substances Antineoplastic Agents
    Language French
    Publishing date 2012-07
    Publishing country France
    Document type English Abstract ; Journal Article
    ZDB-ID 2246755-5
    ISSN 1268-6034
    ISSN 1268-6034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies.

    Giroux Leprieur, Etienne / Jablons, David M / He, Biao

    Oncotarget

    2018  Volume 9, Issue 18, Page(s) 14680–14691

    Abstract: The Sonic Hedgehog (Shh) pathway is physiologically involved during embryogenesis, but is also activated in several diseases, including solid cancers. Previous studies have demonstrated that the Shh pathway is involved in oncogenesis, tumor progression ... ...

    Abstract The Sonic Hedgehog (Shh) pathway is physiologically involved during embryogenesis, but is also activated in several diseases, including solid cancers. Previous studies have demonstrated that the Shh pathway is involved in oncogenesis, tumor progression and chemoresistance in lung cancer and mesothelioma. The Shh pathway is also closely associated with epithelial-mesenchymal transition and cancer stem cells. Recent findings have revealed that a small proportion of lung cancer cells expressed an abnormal full-length Shh protein, associated with cancer stem cell features. In this paper, we review the role of the Shh pathway in thoracic cancers (small cell lung cancer, non-small cell lung cancer, and mesothelioma) and discuss the new perspectives of cancer research highlighted by the recent data of the literature.
    Language English
    Publishing date 2018--06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.24411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma.

    Giroux-Leprieur, Etienne / Dumenil, Coraline / Chinet, Thierry

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

    2018  Volume 13, Issue 11, Page(s) e232–e234

    MeSH term(s) Acrylamides/pharmacology ; Acrylamides/therapeutic use ; Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Aged ; Aniline Compounds/pharmacology ; Aniline Compounds/therapeutic use ; Crizotinib/pharmacology ; Crizotinib/therapeutic use ; Erlotinib Hydrochloride/pharmacology ; Erlotinib Hydrochloride/therapeutic use ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Middle Aged ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
    Chemical Substances Acrylamides ; Aniline Compounds ; Protein Kinase Inhibitors ; osimertinib (3C06JJ0Z2O) ; Crizotinib (53AH36668S) ; Erlotinib Hydrochloride (DA87705X9K)
    Language English
    Publishing date 2018-10-17
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 2432037-7
    ISSN 1556-1380 ; 1556-0864
    ISSN (online) 1556-1380
    ISSN 1556-0864
    DOI 10.1016/j.jtho.2018.07.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.

    Bellouard, Marie / Donadieu, Jean / Thiebot, Pauline / Giroux Leprieur, Etienne / Saiag, Philippe / Etting, Isabelle / Dugues, Pamela / Abe, Emuri / Alvarez, Jean-Claude / Larabi, Islam-Amine

    Pharmaceutics

    2023  Volume 16, Issue 1

    Abstract: Tyrosine kinase inhibitors (TKIs) are used as targeted cancer therapies in adults and have an off-label pediatric application for the treatment of Langerhans cell histiocytosis. A multitarget LC-MS/MS method was developed and validated for the ... ...

    Abstract Tyrosine kinase inhibitors (TKIs) are used as targeted cancer therapies in adults and have an off-label pediatric application for the treatment of Langerhans cell histiocytosis. A multitarget LC-MS/MS method was developed and validated for the determination of alectinib, alectinib-M4, binimetinib, cobimetinib, crizotinib, dabrafenib, encorafenib, imatinib, lorlatinib, osimertinib, AZ5104, and trametinib. A total of 150 µL of internal standard methanolic solution was added to 50 µL of plasma sample to precipitate proteins. After centrifugation, 10 µL of the supernatant was injected into the chromatographic system. The chromatographic separation was conducted on a Kinetex C18 Polar column with a gradient of 2 mM ammonium formate in 0.1% formic acid and acetonitrile over 5 min. Limits of detection and quantification, linearity, accuracy, precision, selectivity, carryover, matrix effect, recovery, and stability were evaluated and satisfied EMA guidelines on bioanalytical methods. This method has been successfully applied to the therapeutic drug monitoring (TDM) of adults with melanoma and lung cancer, as well as children with histiocytosis, to improve the pharmacokinetic data for these drugs, with the aim of enhancing the therapeutic management and follow-up of patients. Blood concentrations of trametinib and binimetinib were different in the two groups, highlighting the age-related inter-individual variability of these molecules and the need for TDM.
    Language English
    Publishing date 2023-12-19
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics16010005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top